SARS coronavirus vaccine development.
Baric
Ralph S
RS
University of North Carolina at Chapel Hill, 27599, USA.
Sheahan
Timothy
T
Deming
Damon
D
Donaldson
Eric
E
Yount
Boyd
B
Sims
Amy C
AC
Roberts
Rhonda S
RS
Frieman
Matthew
M
Rockx
Barry
B
D000818:Animals; D019143:Evolution, Molecular; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D008957:Models, Genetic; D009500:Neutralization Tests; D019590:Nucleocapsid Proteins / Q000378:metabolism; D010802:Phylogeny; D045473:Severe acute respiratory syndrome-related coronavirus / Q000235:genetics*; D045169:Severe Acute Respiratory Syndrome / Q000517:prevention & control*; D014759:Viral Envelope Proteins / Q000378:metabolism; D014765:Viral Vaccines
D019590:Nucleocapsid Proteins; D014759:Viral Envelope Proteins; D014765:Viral Vaccines